Acino offers high-quality pharmaceutical products in advanced drug delivery systems. Our special focus on narcotics and extended release formulations contributes to improving the treatment options available in the fields of cardiovascular, infectiology, central nervous system (CNS), urology and pain management. We are committed to partnering with companies to bring life-changing treatments to patients worldwide, and want to expand our product portfolio within multiple therapeutic areas, such as Oncology.
Acino has a long track record in licensing-out dossiers developed in-house to European customers, from multinationals to local players. Our medicines are manufactured in our Swiss plants and packed either in Switzerland or Estonia. Additionally, we have the flexibility to outsource manufacturing to selected partner companies, which enable us to accommodate different market demands and effectively broaden our reach.
Our fully-integrated services cover all aspects of pharmaceutical development, including intellectual property, market analysis, regulatory support, legal expertise, and efficient supply chain management. EU batch release can be handled by our Estonian or German sites. Serialization including aggregation is possible since November 2018 on and helps tracking all our products over the globe, thus avoiding falsification of medicines for the benefit of patients.
We offer a comprehensive range of services and expertise to meet the needs of our customer. Whether you opt for the entire service chain or have individual needs, we provide top-quality work, something every customer can rightfully expect from us.
The highest standards of ethics and integrity are upheld across all of Acino’s operations. All business transactions, including license agreements, supply agreements, confidentiality agreements, mergers and acquisitions, and more, are supported by our legal team.
Finally, our IP team provides guidance on the worldwide intellectual property rights of all pharmaceutical goods.
Quality is part of our DNA and we are motivated to ensure high-quality products for our patients. Acino is committed to be compliant with all the applicable laws, guidelines as per cGMPs and applicable normatives ensuring the safety, efficacy and quality of our products.
Our Acino quality standards can ensure compliance not only with Swissmedic and EU GMP standards, but also with all the international markets where we operate.
All necessary aspects associated with quality, safety and efficacy of our products are governed by a number of both corporate and local documents such as Quality Manual, Quality Directives, and Standard Operating Procedures.
Our Regulatory department has large experience in defining the regulatory strategy in Europe for new molecules and in running DCPs, MRPs or national procedures. Maintenance of the products during their lifecycle to comply with regulations is an important task for them.
Customer satisfaction is our top priority. Our dedicated customer support team is always available to assist our clients and address any concerns or issues they may have. We strive to provide exceptional service and value to our customers.
With over 50 years of experience in oral solid dosage (OSD) forms. Our dedicated team of experts ensure the efficient and reliable production of high-quality pharmaceutical products.